Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Medicare Advantage grows into a $10B-plus opportunity for go-getter brokers selling plans for private insurers
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
Trump’s SEC eliminates 50-year-old ‘gag rule’ for enforcement settlements
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
Why RadNet is betting heavily on AI to reshape radiology workflows
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
Optum Rx outlines changes to PBM business model, promising price transparency
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
Heartflow reports significant revenue growth as CCTA sees wider adoption
The company keeps gaining momentum thanks to the success of its AI-powered imaging software.

How the Mark Cuban prescription drug playbook could save taxpayers billions

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes

Merck sues US government over Medicare's drug price negotiation liberties, calls program a 'sham'

Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.

Fortune 500's top 10 healthcare companies

A total of 80 healthcare companies are among those that brought in the most revenue for the fiscal year, according to the magazine's most recent rankings.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

87% of mammography centers now have 3D breast imaging systems

Rapid adoption of digital breast tomosynthesis has increasingly made it a new standard of care.

Layoffs up 287% in first 5 months of 2023; healthcare sector not immune

Healthcare companies, including manufacturers that produce health products, announced a total of 33,085 layoffs in the first five months of 2023—an 81% increase compared to the same time frame in 2022.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Business Intelligence

Medicare Advantage grows into a $10B-plus opportunity for go-getter brokers selling plans for private insurers

Trump’s SEC eliminates 50-year-old ‘gag rule’ for enforcement settlements

Why RadNet is betting heavily on AI to reshape radiology workflows

Optum Rx outlines changes to PBM business model, promising price transparency

Heartflow reports significant revenue growth as CCTA sees wider adoption